Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I don't think there's a trading halt:
http://www.nasdaqtrader.com/Trader.aspx?id=TradeHalts
Inventergy Innovations Enters Into a Commercial Agreement With Lopoco
Third Commercial Agreement for Inventergy Subsidiary
CAMPBELL, CA -- (Marketwired) -- 08/03/16 -- Inventergy Global, Inc. (NASDAQ: INVT), an intellectual property licensing company, announced today that Inventergy Innovations, LLC, INVT's recently formed subsidiary, has secured a commercial agreement with Lopoco, a Company that designs and manufactures ultra-efficient green-tech servers. As part of the agreement, Inventergy Innovations will be the exclusive representative in the licensing of Lopoco's technology, which uses up to 75% less energy and 50% less space than conventional servers.
Lopoco's servers are engineered for energy efficiency, rack-space density and low power consumption through the selection of off-the-shelf energy-efficient components, the reduction or elimination of unnecessary power-hungry features, and the advanced engineering of the overall server for efficiency and power savings. Lopoco's servers achieve much higher server densities per rack with significantly lower power and cooling requirements, thus providing advantages in throughput as well as virtual machine, or VM, deployment efficiencies. Lopoco's technology is aimed at markets with high demand for energy efficient products. A recent article in The San Jose Mercury News stated that companies with large data centers spend an aggregate of approximately $7 billion a year on electricity, even with improvements to energy efficiency. Lopoco servers are ideally positioned in a growing market of data center servers, which, according to IDC, is an approximately $60 billion per year market.
Joe Beyers, CEO of Inventergy, stated, "We are excited to be partnering with Lopoco in licensing its groundbreaking, ultra-efficient technology. In a short time, Inventergy Innovations has been able to secure the license rights to unique and powerful disruptive technology and we believe this will allow us to provide additional revenue opportunities for Inventergy Innovations and our partners. This is our third commercial agreement as part of this initiative, with more coming. Progress is also being made on previously signed agreements as we have already initiated licensing and partnership discussions relating to these opportunities."
"We are pleased with our decision to partner with Inventergy Innovations to maximize our growth potential in this dynamic server market," said Andy Sharp, CEO of Lopoco. "Our ultra-efficient server design uses far less power than conventional servers without compromising performance or business continuity. Our servers are built on proven, currently available technology, without costly custom silicon. We chose to work with Inventergy Innovations because of its reputation and successful IP strategies."
About Inventergy Global, Inc.
Inventergy Global, Inc. is a Silicon Valley-based intellectual property company dedicated to identifying, acquiring and licensing patented technologies of market-significant technology leaders. Led by IP industry pioneer and veteran Joe Beyers, the Company leverages decades of corporate experience, market and technology expertise, and industry connections to assist Fortune 500 and other technology companies in leveraging the value of their innovations to achieve greater returns. For more information about Inventergy, visit www.inventergy.com.
Cautionary Statement Regarding Forward-Looking Statements
This press release contains statements, estimates, forecasts and projections with respect to future performance and events, which constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Those statements include statements regarding the intent and belief or current expectations of the Company and its affiliates and subsidiaries and their respective management teams. These statements may be identified by the use of words like "anticipate," "believe," "estimate," "expect," "intend," "may," "plan," "will," "should," "seek" and similar expressions and include any projections or estimates set forth herein. Investors and prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, that actual results may differ materially from those projected in the forward-looking statements.
Source: Inventergy Global, Inc.
Released August 3, 2016
Soloman, oh Soloman.
He always sounds so proud of himself.
What nightmares his claims seem to give us
as long term shareholders.
I wonder if he's somehow related to Donald Trump.
Let's hope it is a long overdue financing deal.
This management team has kept us hanging way, way too long.
Just found this posted on Jordan Fund.
Please, please someone provide a better translation.
"A company of today, initially in the United States received an imposition was SIAF, with Stryck time now. The pendulum has been between + 9 + 7% at this writing."
Steady buying of a few hundred shares seems to continue.
I wonder if SIAF finally got its financing?
Up strong this am!!
Any ideas why?
President’s Message
natcore-president-chuck-provini
In this message, I’ll bring you up to date on our technology improvements, our search for potential partners and our Best-of-Breed power plant opportunities.
Technology
Remember our mantra: increase the efficiency, lower the cost.
We are making progress with improved efficiencies in our laboratory by focusing most of our research efforts on monocrystalline silicon wafers because of their greater efficiency potential. (In fact, the solar industry is now quickly moving to monocrystalline for that reason.)
And we continue to simplify our process. That translates directly to reducing cost at competitive or improved efficiencies in the market.
One of the areas of improvement is our scientists have identified better light wavelengths for our laser process. As an example, infrared light, which cannot be seen by humans, is traditionally used in the laser process. Our scientists have found that this infrared light is only weakly absorbed by silicon, which limits the ability to precisely tailor laser pulses. As a result, they have created a new set of optical components that convert light to green, which is absorbed 100 times more effectively by the silicon. These optics allow us to use whichever wavelengths are needed and help push our progress further along.
Additionally, we are continually simplifying the process used to produce our aluminum foil bi-layer cells. We recently have demonstrated that by slight modifications of the composition of an important conductive layer, we eliminate a sequence of patterning steps that we have been using up until now. This simplification has a direct correlation to reducing costs.
Potential partners
The improvement in the foil bi-layer cells has added another dimension to our search for a partner whose scale and resources can help us reach the ultra-high-efficiency potential that our cells are capable of.
Until now, we’d been limiting our quest to cell manufacturers and other companies in the solar industry. But our advances with the Natcore Foil Cell™makes us attractive to aluminum foil manufacturers who want to expand into new, high-margin markets.
By giving the rights to produce our proprietary foil to an aluminum company partner, we would also be giving them the opportunity to gain access to the solar industry. Included in our package would be some type of exclusivity in providing this unique foil in conjunction with license agreements to cell manufacturers. We believe that it is a much simpler sell to the aluminum companies at this stage of our development.
Best of breed
I continue to believe that our first important revenue will come from our Best of Breed program, which continues to capture the interest of major international projects. Recently I was hosted by the developers of the Belize project. I met all the partners and viewed the site for the proposed power facility, which is adjacent to the international airport that they are currently building. The funding for the solar project is part of the airport funding. This airport is currently 60% completed.
We are also currently negotiating agreements with and hope to be chosen by a developer who is known very well to us to participate in a multi-faceted facility in a Middle Eastern country. We are at a similar level in negotiations with a Sgoutheast Asian country. These latter two projects are each in excess of 500 MW. Each has contingent financing; one of them also has a sovereign government guarantee.
I hope this gives you some idea of the significance of our unique cell technology as well as our flexibility in identifying potential markets, whether they be obvious or outside the box.
Chuck Provini, President, CEO & Director
New SIAF commentary on Jordan Fund site. Please, someone, provide a better translation of this post.
"Is it SIAFs turn now? 2016-07-03 00:10
Now we go into Q3 and everyone remembers last teleconference and the latest press notices of spin-offs, financing and other sketches of the future. It will be exciting to follow the company in after-Brexit environment on the floor of the exchange. First class organic food, seafood as well as vegetables like steak.
JF hope to continue in a positive scenario for organically produced food. The debris with water inflated tasteless antibiotikapumpad 3-week-chicken and Norwegian farmed salmon with questionable feed, pulp antibiotics and large amounts of color (all salmon largely from Norwegian farms are colored in a 12-point red scale customer requirements - Japan wants rödast ). The chicken should be replaced by organically produced good healthy poultry products. Norwegian salmon is classified inedible for humans in the circuits can industry. SIAFs echo jumbo shrimp and fish and eels are useful good health. Also in China makes now increasingly tough demands on the food - the government is aware of this and slopes SIAF in more ways than one."
Inventergy Global, Inc. to Be Granted 23 New Patents in Telecommunications and Mobile Broadband
Download PDF
Company Expands Telecommunications and Mobile Broadband Coverage Adding Patents in US and Europe
CAMPBELL, CA -- (Marketwired) -- 06/22/16 -- Inventergy Global, Inc. (NASDAQ: INVT), an intellectual property licensing company, announced today that it has received patent grants and notices of allowance (indicating that a patent application qualifies for a patent) for a total of 23 patents. These previously pending patent applications include 15 patents in five families of the IMS/VoIP (IP Multimedia Subsystems/Voice over IP) portfolios originally purchased from Nokia and Huawei and eight patents in three families included in the Mobile Broadband portfolio originally purchased from Panasonic.
Joe Beyers, CEO of Inventergy, stated, "We continue to invest in enhancing our patent portfolio and bringing patent applications to issuance so that we may broaden our monetization revenue stream. This requires a deep technical understanding of our technology assets and the ability to effectively respond to patent examination issues from various patent offices worldwide. The addition of these new patent assets will further strengthen the value and relevancy of our portfolio in the IMS/VoIP infrastructure, mobile broadband infrastructure and mobile user equipment areas for both 3G and 4G systems."
The technology covered by the patents relates to:
IMS/VoIP Families
1. Three European (EP) patents, granted in Germany, France and Great Britain and originally filed by Huawei, define a resource control method to reduce network traffic by allowing multimedia sessions to flow directly between parties within their access network without taking multiple paths (known as tromboning) through the IMS core network. This translates into higher networking data rates and lower latency to users while freeing up bandwidth in the IMS core network.
2. Three EP patents, granted in Germany, France and Great Britain and originally filed by Huawei, enhance network latency and performance for users by providing a resource control method for finding the most efficient network access when a UE device (e.g. cell phone) has multiple network access capability. Users see quicker connection times and best data rates among the available networks.
3. Five EP patents, granted in Germany, France, Great Britain, Finland and Sweden and originally filed by Huawei, reduce connection time and provide higher voice clarity by providing an efficient method to select the optimum codec (voice coding and decoding software) to be used between users communicating via voice.
4. A US patent originally filed by Nokia provides an efficient method for authentication of a user device as it connects to an IMS core network. Information is carried via the user equipment's access network thereby reducing connection time and providing more reliable authentication. This translates to faster call connection and fewer network delays for users.
5. Three EP patents, to be granted in Germany, France and Great Britain and originally filed by Nokia, provide a more robust and scalable way of signaling between packet-based multimedia steams, allowing for faster and more reliable connections to and between user devices, especially in heavy traffic environments.
MBB Families
1. Three EP patents, granted in Germany, France and Great Britain and originally filed by Panasonic, define a method of power control for user equipment (UE) devices in 3G cellular networks. Precise control of UE transmitted power keeps users in a cell from interfering with each other, while reducing dropped calls and allowing more users within a cell.
2. Three EP patents, to be granted in Germany, France and Great Britain and originally filed by Panasonic, provide a higher speed ARQ (automatic retransmission request) in light of transmission errors, allowing faster data rates and faster communications in LTE cellular systems.
3. Two patents from the same family, to be granted in the US and originally filed by Panasonic, are relevant to LTE cellular communication systems. They provide for a higher speed ARQ when cellular systems are using multiple antennas leading to increased data rates of cellular networks and increased bandwidth, allowing higher performance when multiple users are sharing the resources in a cell.
About Inventergy Global, Inc.
Inventergy Global, Inc. is a Silicon Valley-based intellectual property company dedicated to identifying, acquiring and licensing patented technologies of market-significant technology leaders. Led by IP industry pioneer and veteran Joe Beyers, the Company leverages decades of corporate experience, market and technology expertise, and industry connections to assist Fortune 500 and other technology companies in leveraging the value of their innovations to achieve greater returns. For more information about Inventergy, visit www.inventergy.com.
Cautionary Statement Regarding Forward-Looking Statements
This press release contains statements, estimates, forecasts and projections with respect to future performance and events, which constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Those statements include statements regarding the intent and belief or current expectations of the Company and its affiliates and subsidiaries and their respective management teams. These statements may be identified by the use of words like "anticipate," "believe," "estimate," "expect," "intend," "may," "plan," "will," "should," "seek" and similar expressions and include any projections or estimates set forth herein. Investors and prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, that actual results may differ materially from those projected in the forward-looking statements.
Source: Inventergy Global, Inc.
Released June 22, 2016
Waiting (Im)patiently!!
Where's the Beef?
In true SIAF tradition announcements never
appear until the very last moment.
I guess we now have 'till right before the
market opens on Monday.
But which market opening will it be?
Please tell us what the final trade was.
China PV firm does solar cell production tests for Natcore tech
A leading Chinese PV manufacturer has performed production line tests for silicon solar cell technology developed by US firm Natcore. The unnamed Chinese firm, which Natcore Technology refers to as “one of the world’s largest PV manufacturers,” is the the first firm to process its black silicon wafers into working solar cells on a production line, rather than in a laboratory setting.
Scientists at Natcore used the US technology company’s proprietary process to give the wafers a black silicon etch. The wafers were then shipped to the photovoltaic manufacturer, based in China’s Hunan province.
Five batches of silicon wafers with a black silicon etch were supplied to the Chinese company for solar cell finishing and testing. The wafers were prepared by Natcore’s scientists at its R&D centre in Rochester, New York.
Natcore said two of the batches were used as controls to help interpret results. Of the three test batches, one had a diffusion using phosphorous oxychloride applied by Natcore; the remaining test batches were diffused by the Chinese company. In all cases, the Chinese team performed the final steps necessary to turn the wafers into solar cells and to test them, with positive results, Natcore said.
David Levy, Natcore’s director of research and technology, said: “We put these cells through the Chinese manufacturer’s process with essentially no modification to the process itself, except for the fact that certain steps were completely removed. And the removal of these steps projects to yield cost savings of as much as 23.5 per cent.
“We came out with an efficiency of 15.7 per cent on this first trial. The Chinese team said they were very impressed, as we were, with this result,” he said. “Conventional cells made in a similar industrial process do have efficiencies in the range of 17 to 19 per cent. But considering the results of this first attempt, the Chinese engineers feel that we could easily push our black cell efficiency into the high teens.”
Chuck Provini, Natcore’s president and CEO, said the development demonstrates a “huge step” towards commercialisation.“I can’t overstate the importance of this development. It demonstrates that our black silicon process is commercially viable in a real production line,” Provini said. “It also shows that our process could be integrated into a production line without fear of contamination by the chemicals that our process uses.
“This is a huge step toward commercialisation. It proves our earlier contention that our technology can easily be retrofitted into existing solar cell production lines and can just as easily be incorporated into a new line. Black silicon seems poised to become an important new approach for the industry.”
The completed cells are being returned to Natcore for further testing.
Management Incentives:
Hello xxxxxxxxxxxx,
I will check, but I am 95% certain that the shares are restricted, likely for six months. Ax a matter of record. I believe that neither the CEO nor any other other Board member has ever sold any shares.
Best Regards,
Peter Grossman
Investor Relations
Sino Agro Food, Inc.
Even more selling this morning as current shareholders
express their displeasure at management's selfish share grants.
I'll continue to hold (even at a small paper loss) to listen to the
conference call and see if management starts to dump their own shares or if they finally decide that enough is enough.
Does anyone have a web site I can use to hear the conference call?
New hire one month ago!!
Old News
GW Pharmaceuticals Receives Orphan Drug Designation from FDA for Cannabidiol for the Treatment of Tuberous Sclerosis Complex
Print
Alert
GW PHARMACEUTICALS PLC (NASDAQ:GWPH)
Intraday Stock Chart
Today : Thursday 21 April 2016
Click Here for more GW PHARMACEUTICALS PLC Charts.
GW Pharmaceuticals plc (Nasdaq:GWPH) (AIM:GWP) (“GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for cannabidiol (CBD) for the treatment of Tuberous Sclerosis Complex (TSC). TSC is a rare genetic disorder, the most common symptom of which is epilepsy. Epilepsy occurs in around 80-90% of TSC patients and is a significant cause of morbidity and mortality. TSC is the third orphan indication that GW is targeting within its Epidiolex® (CBD) clinical development program, which includes four Phase 3 pivotal trials in Dravet syndrome and Lennox-Gastaut syndrome, both rare and catastrophic forms of childhood-onset epilepsy. On April 11, 2016, GW announced it has commenced a Phase 3 clinical trial of Epidiolex® as an adjunctive therapy for the treatment of seizures associated with TSC.
To obtain information about this clinical trial or eligibility criteria, the treating physician should contact: medicaldirector@gwpharm.com
About Orphan Drug Designation
Under the Orphan Drug Act, the FDA may grant orphan drug designation to drugs intended to treat a rare disease or condition - generally a disease or condition that affects fewer than 200,000 individuals in the U.S. The first NDA applicant to receive FDA approval for a particular active moiety to treat a particular disease with FDA orphan drug designation is entitled to a seven-year exclusive marketing period for that drug and use, unless the applicant is unable to assure sufficient quantities of the drug or another applicant is able to demonstrate that its version of the drug is clinically superior.
About Tuberous Sclerosis Complex (TSC)
TSC is a genetic disorder that causes non-malignant tumors to form in many different organs, with the brain and skin being the most commonly affected tissues. There are approximately 50,000 in the United States and nearly 1 million people worldwide estimated to have TSC1. Epilepsy is the most common presenting symptom in TSC and is also the most common medical disorder in TSC. Up to 80 to 90% of individuals with TSC will develop epilepsy during their lifetime, with onset typically in childhood. The majority of children with TSC have onset of seizures during the first year of life, and up to one third of children with TSC will develop infantile spasms. Almost all seizure types can be seen in individuals with TSC, including tonic, clonic, tonic-clonic, atonic, myoclonic, atypical absence, partial, and complex partial. The seizures are often severe, and up to two-thirds of TSC patients do not respond adequately to available medical therapies. There are significant co-morbidities associated with TSC including cognitive impairment, autism spectrum disorders, and neurobehavioral disorders in individuals with TSC. 2
References:
1: http://www.tsalliance.org/pages.aspx?content=585
2: http://www.medscape.com/viewarticle/495644
About Epidiolex
Epidiolex, GW’s lead cannabinoid product candidate, is a liquid formulation of pure plant-derived CBD, which is in development for the treatment of a number of rare pediatric epilepsy disorders. GW has conducted extensive pre-clinical research of CBD in epilepsy since 2007. This research has shown that CBD has significant anti-epileptiform and anticonvulsant activity using a variety of in vitro and in vivo models and has the ability to treat seizures in acute animal models of epilepsy with significantly fewer side effects than existing anti-epileptic drugs. To date, GW has received Orphan Drug Designation from the U.S. Food and Drug Administration (FDA) for Epidiolex in the treatment of Dravet syndrome, Lennox-Gastaut syndrome and TSC. Additionally, GW has received Fast Track Designation from the FDA and Orphan Designation from the European Medicines Agency for Epidiolex for the treatment of Dravet syndrome. GW is currently evaluating additional clinical development programs in other orphan seizure disorders.
About GW Pharmaceuticals plc
Founded in 1998, GW is a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas. GW commercialized the world’s first plant-derived cannabinoid prescription drug, Sativex®, which is approved for the treatment of spasticity due to multiple sclerosis in 28 countries outside the United States. GW is advancing an orphan drug program in the field of childhood epilepsy with a focus on Epidiolex® (cannabidiol), which is in Phase 3 clinical development for the treatment of Dravet syndrome, Lennox-Gastaut syndrome and Tuberous Sclerosis Complex. GW has a deep pipeline of additional cannabinoid product candidates which includes compounds in Phase 1 and 2 trials for glioma, type 2 diabetes, schizophrenia and epilepsy. For further information, please visit www.gwpharm.com.
On April 18, 2016, Apple, Inc. and Dynamic Advances, LLC, a wholly-owned subsidiary of the Company, entered into a settlement agreement under which the Company agreed to dismiss with prejudice the pending litigation in the United States District Court of and for the Northern District of New York “ Rensselaer Polytechnic Institute and Dynamic Advances LLC v. Apple Inc.” Under the terms of the settlement Apple, will receive a patent license from Dynamic Advances and a 3-year covenant not to sue from the Company. Other than as contained herein, the terms of the settlement are confidential.
Apple will pay $24.9 million under the settlement agreement. $5 million is payable upon dismissal of the pending litigation and an additional $19.9 million upon the occurrence of any one of the following:
· Consent to the license by Rensselaer Polytechnic Institute (“RPI”);
· Dismissal of the pending litigation with prejudice;
· A final decision by a court holding that Dynamic Advances has authority to grant the license in the settlement; or
· The expiration or invalidity of the patents in suit.
Dynamic Advances expects to pay an aggregate of approximately 50% of the gross proceeds to RPI, Dynamic Advances’ legal counsel and the predecessor exclusive licensee of the patents in suit.
Dynamic Advances believes RPI has unreasonably withheld its consent to the reasonable royalty rate set forth in the settlement agreement between Dynamic Advances and Apple, and that issue may have to be resolved in arbitration, but it will not deter the resolution between Apple and Dynamic Advances. The Company is unable to predict the resolution of any such arbitration.
The Company believes that the settlement agreement has been entered in the ordinary course of business and, accordingly, has not been filed as an exhibit hereto in accordance with Item 6.01(b)(10)(ii) of Regulation S-K under the Securities Act of 1933, as amended. Dynamic Advances believes that other voice recognition products infringe the ‘798 patent.
This Current Report on Form 8-K contains these types of statements, which are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, and which involve risks, uncertainties and reflect the Company’s judgment as of the date of this Current Report on Form 8-K. The preceding paragraph contains forward-looking statements. These statements are subject to inherent uncertainties and risks that could cause actual results to differ materially from those anticipated at the date of this Current Report on Form 8-K. You are cautioned not to rely unduly on forward-looking statements when evaluating the information presented within.
The information contained in this Current Report on Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. The furnishing of the information in this Current Report on Form 8-K is not intended to, and does not, constitute a representation that such furnishing is required by Regulation FD or that the information contained in this Current Report on Form 8-K constitutes material investor information that is not otherwise publicly available.
First Million shares traded already.
Coin, just a thought to bounce off you.
Natcore getting a percentage of the proceeds from the Belieze plant's sales sounds too good to be true unless some of our state of the art technology will later be incorporated in the plants design.
Maybe this announcement will be followed up with some very interesting
others as soon as the missing pieces fall into place.
Comments??
Do you think we'd design a plant that didn't include our technology?
Do you think we'd be the prime designer if the customer didn't want
our technology?
I think we're the only people who noticed this announcement!
But finally, we'll realize a 21st century manufacturer that utilizes our latest technologies.
Even better, Natcore "will have unencumbered equity in the project.
Natcore Technology Engaged To Develop 10mw Solar Facility
Project Originates From Natcore’s “Best of Breed” Program
Rochester, NY — (March 22, 2016) — Natcore Technology Inc. (TSX-V: NXT; OTCQB: NTCXF) has been engaged to oversee development of a 10MW photovoltaic solar array in Belize.
Natcore will oversee development of the project in conjunction with Catalyst565, Inc., a globally oriented and regionally diversified energy development company headquartered in New York City.
The 90-acre solar power installation will be located in Placencia, a small town and a significant tourism destination located in Belize. Catalyst565 will capitalize pre-development expenses and will bring together the key partners needed for this project, with Natcore serving as the technology partner and advisor.
The project came to Natcore via its “Best of Breed” program, through which the company functions as a consultant on the design and construction of solar cell/solar panel fabrication facilities and solar farms. Natcore will be compensated on a “cost-plus” basis and will have unencumbered equity in the project.
While this solar power project will provide important commercial revenue to Natcore, it will not distract from the company’s primary mission of bringing paradigm-shifting solar technology to the industry. Natcore’s R&D program continues to advance, and the latest results will be reported soon.
For the Belize power plant, Natcore will guide Catalyst565 in procuring components of the highest quality at the best prices available, taking advantage of Natcore’s preferential status in the solar industry. Natcore will also select and oversee the EPC (engineering, procurement and construction) firm for the project.
Since Natcore is not itself a manufacturer, it is able to buy components or employ vendors without bias. Thus, Natcore will have the freedom to provide optimum products with appropriate warranties and efficiencies.
“We developed ‘Best of Breed’ in response to requests from entities that wanted access to our advances in solar technology,” says Chuck Provini, Natcore president and CEO. “The Belize project has some site-specific requirements that will enable us to flex our muscles.” For example, in 2001 Hurricane Iris hit the region with 145 mph winds, causing major damage to most buildings in Placencia. Because of that history, Natcore is planning a hurricane-proof array for this installation.
Catalyst565 is centered on developing renewable energy by converting municipal waste, plastics and used tires into fuel oil and diesel fuel and directly into electricity. Catalyst565 currently is developing projects in the US Virgin Islands, Canada, Germany and the Netherlands.
“We’re always looking for new energy technologies, but we’ve found it best to be a technology-agnostic company,” says Brent Borland, Managing Director of Catalyst565. “That is, we have a non-committal attitude toward a given technology until we’ve given it a thorough vetting. Natcore was selected because of the acknowledged expertise of its solar scientists and engineers.”
About Natcore Technology
Natcore Technology is focused on using its proprietary nanotechnology discoveries to enable a variety of compelling applications in the solar industry. Specifically, the company is advancing applications in laser processing, black silicon and quantum-dot solar cells to significantly lower the costs and improve the power output of solar cells. With 63 patents (27 granted and 36 pending) Natcore is on the leading edge of solar research. www.NatcoreSolar.com
I hope you're right. But maybe management overlooked these provisions
because they really needed the cash.
Interesting thought.
I'm not sure Natcore is really in control of the timeline. Maybe their customers have to raise their own money to follow through with the commitments they would like to make.
What I don't like to see are big volume selloffs like happened yesterday. I suspect that the private placements may be backfiring on Natcore with the purchaser(s) of the placements selling off their shares and holding onto their options.
Good News. The private placement is complete. Therefore the silent period is over.
Maybe, just maybe, the company can now tell us if we have any real sales.
No reason to be discouraged so far.
Following is a reply I received from Peter Grossman just yesterday.
I had inquired about megafarm status.
"There have been delays with initial stocking of the "Mega Farm," as has been communicated. I can assure you that the viability of the project is not in question. In fact, at the same time the delay was explained, the Company also communicated work was progressing on the second stage of the first phase of the project. therefore, whereas initial stocking was delayed, later stage production is not delayed from earlier projections.Therefore, the production ramp is likely to be faster than originally projected; albeit, starting later.
I fully expect there will be a public update on progress in the relatively near future, as all material information must be disseminated to all. Perhaps even the date of an update could be deemed material, I suppose."
Let's just watch what happens in the last few minutes of the day.
That's where the SIAF story has been told recently.
patentminer... As we expected. Great find.
Back to $1.63. Market's been horrible lately. Maybe someone
got a margin call and had to sell something to cover.
Looks good. Thank you.
Anything happening in Oslo this morning?
It's a bit confusing to observe the recent drop
in share price. Next week someone is going to get
a real shock.
Hope it's not the recent "anti-RD" who has decided to
trade in accordance with his new insight!!
Not money manager trading... Its money manager
manipulation.
Full position now complete thanks to
the Swedish holiday. Today I thank and
bless the shorters!! What a gift!!
Now let's see water flowing in the MegaFarm announced before
Jan 13th!!
OncoCyte Starts Trading on NYSE MKT
On December 31,2015. On 12/31/15
Biotime (BTX) distributed about 4.8 million
OncoCyte shares to its shareholders.
Let's see if this end of day pattern continues next week.
I perceive that someone is attempting to accumulate a sizable
position without showing much change in the closing price.